[Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D002951:Citrates / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005415:Flavins / Q000627:therapeutic use; D007501:Iron / Q000627:therapeutic use; D007773:Lactates / Q000627:therapeutic use; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010710:Phosphates / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy*; D014803:Vitamin B Complex / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002951:Citrates; D004338:Drug Combinations; D005415:Flavins; D007773:Lactates; D010710:Phosphates; D014803:Vitamin B Complex; D007501:Iron; D011188:Potassium
Unwirksamketi eines Kombinationspräparates am Yoshida-Sarkom und am Walker-Carcinosarkom 256 der Ratte sowie am Ehrlich-Carcinom der Maus.